Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Ratnakar Lavu is EVP & Chief Digital Info Ofr at Elevance Health. OQRO lists 6 transactions filed with the SEC under this name, the latest on Nov 6, 2026, each linked to the official Form 4.
EVP & Chief Digital Info Ofr
Disclosures on record
6
Companies involved
1
As of the latest filing on , Ratnakar Lavu reported holding 14,849 shares of Elevance Health (ELV), worth about $5.95M at the last close of $401 (Nov 18, 2026). In the last 12 months, Ratnakar Lavu sold $572K in 1 sale.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Elevance Health ELV | 14,849 | 15K direct | $401 | $5.95M | Nov 5, 2026 |
Is this Ratnakar Lavu’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Elevance HealthELV
6 disclosures · Mar 2026 – Nov 2026 · 1 sold
Nov 5, 2026Sold~$572Kdisclosed Nov 6
DetailsOfficial recordMar 2, 20265,101disclosed Mar 4
DetailsMar 2, 20266,802disclosed Mar 4
DetailsOfficial recordMar 2, 202620Kdisclosed Mar 4
DetailsOfficial recordMar 2, 2026315disclosed Mar 4
DetailsOfficial recordMar 3, 2026222disclosed Mar 4
DetailsOfficial recordRatnakar Lavu has no open-market purchase on record since 2018 across 2 companies. Sales in 2 of the 9 years since 2018.
Ratnakar Lavu reported 0 open-market purchases and 2 sales since 2018; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2026 | — | $572K1×1 trade |
| 2018 | — | $1M1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 5, 2026, Ratnakar Lavu reported holding 14,849 shares of Elevance Health (ELV). At the last close of $401 on Nov 18, 2026, that is about $5.95M. This is the stake disclosed in filings, not a net worth.
No public filing gives Ratnakar Lavu's net worth. What SEC Form 4 shows is the stock stake: 14,849 shares of Elevance Health (ELV), about $5.95M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
In SEC filings of the last 12 months, Ratnakar Lavu reported 1 open-market sale worth $572K, and no open-market purchase. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
Ratnakar Lavu has no open-market purchase on record since 2018 across 2 companies. Sales in 2 of the 9 years since 2018.
In SEC filings since 2018: no open-market purchase is on record; the latest open-market sale is from 2026.
2 companies: Elevance Health (ELV, 2026), Kohl's Corp. (KSS, 2018).
Ratnakar Lavu reported 0 open-market purchases and 1 sale here, 2026.
Ratnakar Lavu reported 0 open-market purchases and 1 sale here, 2018.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.